As we begin 2021, we’d like to introduce you to our new Blaze Vector™ AAV production line. Utilizing our proprietary HEK 293 suspension Ignition Cells™, which are scalable from 1-50L at research & toxicology grades, we can help accelerate your gene therapy manufacturing rapidly from pre-clinical through cGMP. We also offer process and analytical development to enhance the early success of your gene therapy programs. Learn more about how we can work with you in 2021 at http://fb.xeromedia.com/services/#blaze.

0/5 (0 Reviews)